In a vote on November 9, 2025, the U.S. Senate approved a resolution to reopen the government which includes a Food and Drug Administration (FDA) spending bill that would introduce changes to federal hemp regulations. The bill seeks to close what some describe as a “loophole” that has allowed intoxicating hemp-derived THC products to enter the market since the passage of the 2018 Farm Bill.

On November 12, 2025, the House of Representatives approved the spending package. This was followed by the President’s signature and 365 days from this date, the changes to hemp regulations will go into effect.

On December 18, 2025, President Trump signed an executive order advancing two major policy shifts in federal cannabis and hemp regulation. First, the order directs the Justice Department to take all necessary steps to reschedule cannabis to Schedule III. Second, the order directs the Assistant to the President and Deputy Chief of Staff for Legislative, Political, and Public Affairs to work with the Congress to update the statutory definition of final hemp-derived cannabinoid products so that it allows Americans to access full-spectrum CBD products. This includes establishing a new regulatory framework for the upper limit on milligrams of THC per serving and CBD to THC ratio requirements. This means that the 0.4 milligrams of THC per container limit (scheduled to come into effect in November 2026) may be revised.

The executive order also directs to develop research methods and models that use real-world evidence to evaluate the medical risks and benefits of CBD, “including for specific populations and conditions”. This initiative responds to growing data showing CBD’s effectiveness in improving patient symptoms for common ailments as well as its widespread public use: the order cites that 1 in 5 U.S. adults and nearly 15% of seniors used CBD in the past year.

Although not included in the executive order, Mehmet Oz – the administrator of the Centers for Medicare & Medicaid Services (CMS) – announced the launch of a pilot program in April 2026 under CMS’ Innovation Center that will give millions of Americans on Medicare access to CBD at no charge, provided that they first receive a recommendation from their doctor.

The Origin of the Controversy

The 2018 Farm Bill legalized hemp as cannabis containing no more than 0.3% delta-9 THC on a dry-weight basis. However, it left room for interpretation: products derived from hemp that contain other forms of THC – such as delta-8 THC and and other isomers – have since appeared in convenience stores, gas stations, and online retailers.

Critics argue these products are not truly “hemp” but rather unregulated versions of marijuana, sold without age verification, testing, or oversight. Advocates for state-licensed cannabis businesses say this unregulated market undermines public safety and their own compliance-heavy operations.

What the New Hemp Regulations Do

The Senate’s spending bill includes language that redefine “hemp” more strictly under federal law. Key changes include:

• Total THC cap: Hemp is limited to 0.3% total THC, including THCA (which converts to THC when heated). This closes the so-called “THCA loophole” that allowed high-THC flower to be sold legally if it tested below the 0.3% threshold for delta-9 THC alone.
• Ban on synthetic or non-naturally occurring cannabinoids: Compounds which are chemically altered or synthesized in labs no longer qualify as hemp – even if derived from legal hemp biomass.
• Limit on final products: Any finished hemp-derived product can contain no more than 0.4 milligrams of total THC per container. The term “container” is defined as the “innermost wrapping, packaging or vessel in direct contact with a final hemp-derived cannabinoid product” such as bottles, packets, or cartridges.

source: hempcbdbusinessplans.com

Navigating Regulatory Changes for Your Hemp Business

As federal and state regulations continue to shift, the hemp industry’s future will increasingly favor businesses that operate with transparency, foresight, and strict adherence to the law. A well-structured business plan is not just a roadmap for growth – it is a critical tool for demonstrating legitimacy. Operators who can clearly articulate their compliance protocols, sourcing practices, and product testing standards will be best positioned to withstand regulatory scrutiny, build consumer trust, and secure partnerships in both retail and wholesale channels.

This is where a comprehensive, regulation-aware business plan becomes indispensable – not only for internal planning but also for engaging investors, lenders, and licensing authorities. A strong plan clearly outlines your path to compliance, capital needs, operational structure, and revenue potential.

To help you build that foundation with confidence, HempCBDbusinessplans offers a complete, expert-designed template package tailored specifically for the hemp and CBD sector. It includes:

• Excel Financial Model: change variables and immediately see the impact, break down operational and capital costs, know how much it will take to get into the business and the potential profits.
• Word Business Plan: value proposition, market analysis, marketing strategy, operating plan, organizational structure, financial plan and more.
• PowerPoint Pitch Deck: provide a quick overview of your hemp CBD business plan.

Hemp CBD business plan templates are available at hempcbdbusinessplans.com.